PAVmed Inc.
NASDAQ:PAVM
1.05 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.452 | 0.377 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 9.352 | 3.614 | 0.585 | 0.023 | 0.014 | 0.01 | 0.007 | 0.004 | 0 | 0 |
| Gross Profit
| -6.9 | -3.237 | -0.085 | -0.023 | -0.014 | -0.01 | -0.007 | -0.004 | 0 | 0 |
| Gross Profit Ratio
| -2.814 | -8.586 | -0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 14.276 | 25.547 | 19.847 | 10.963 | 6.63 | 4.253 | 2.619 | 1.72 | 0.489 | 0.022 |
| General & Administrative Expenses
| 30.947 | 41.041 | 25.566 | 12.388 | 7.665 | 6.31 | 5.415 | 3.931 | 1.287 | 0 |
| Selling & Marketing Expenses
| 17.583 | 19.318 | 8.895 | 2.789 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 47.619 | 60.359 | 34.461 | 12.388 | 7.665 | 6.31 | 5.415 | 3.931 | 1.287 | 0.4 |
| Other Expenses
| -1.186 | 1.784 | 0 | 0 | -0.559 | -0.903 | -3.124 | 0 | 0 | 0 |
| Operating Expenses
| 61.895 | 87.69 | 54.308 | 23.351 | 14.295 | 10.563 | 8.034 | 5.651 | 1.777 | 0.549 |
| Operating Income
| -68.795 | -90.927 | -54.393 | -23.351 | -14.295 | -10.563 | -8.034 | -5.651 | -1.777 | -0.422 |
| Operating Income Ratio
| -28.057 | -241.186 | -108.786 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -10.468 | -12.311 | -1.733 | -12.537 | -2.973 | -4.602 | -0.76 | -0 | 0 | -0.126 |
| Income Before Tax
| -79.263 | -103.238 | -56.126 | -35.888 | -17.268 | -18.173 | -9.519 | -5.651 | -1.777 | -0.549 |
| Income Before Tax Ratio
| -32.326 | -273.841 | -112.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -12,993 | -1.944 | -5.779 | -1.559 | -1.337 | -0.204 | 0.879 | -0 | -1.777 | -0.126 |
| Net Income
| -64.175 | -101.294 | -50.347 | -34.329 | -15.931 | -17.969 | -9.519 | -5.651 | -1.777 | -0.549 |
| Net Income Ratio
| -26.173 | -268.684 | -100.694 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -8.87 | -17.06 | -9.74 | -10.86 | -7.91 | -0.81 | -0.71 | -0.44 | -0.13 | -0.96 |
| EPS Diluted
| -8.87 | -17.06 | -9.74 | -10.86 | -7.91 | -0.81 | -0.71 | -0.44 | -0.13 | -0.96 |
| EBITDA
| -65.863 | -92.802 | -54.167 | -23.988 | -15.39 | -12.071 | -11.151 | -5.647 | -1.777 | -0.126 |
| EBITDA Ratio
| -26.861 | -246.159 | -108.334 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |